Managing Atopic Dermatitis with Lebrikizumab – The Evidence to Date

Managing Atopic Dermatitis with Lebrikizumab – The Evidence to Date

Angelina Labib, Teresa Ju, Gil Yosipovitch Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery and Miami Itch Center, University of Miami Miller School of Medicine, Miami, FL, USACorrespondence: Gil Yosipovitch, Email gyosipovitch@med.miami.eduAbstract: Atopic dermatitis is a prevalent...

Full description

Bibliographic Details
Main Authors: Labib A, Ju T, Yosipovitch G
Format: Article
Language:English
Published: Dove Medical Press 2022-06-01
Series:Clinical, Cosmetic and Investigational Dermatology
Subjects:
lebrikizumab
il-13
monoclonal antibody inhibitor
atopic dermatitis
eczema
Online Access:https://www.dovepress.com/managing-atopic-dermatitis-with-lebrikizumab--the-evidence-to-date-peer-reviewed-fulltext-article-CCID

Internet

https://www.dovepress.com/managing-atopic-dermatitis-with-lebrikizumab--the-evidence-to-date-peer-reviewed-fulltext-article-CCID

Similar Items